← Open Payments lookup

SHELLEY GOUGH: Open Payments

NPI 1164019501 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$387 in 22 payments from 10 companies in 2025. Trend: 2023 $514 · 2024 $461 · 2025 $387

Food & beverage: $387
CompanyPaymentsAmount
ABBVIE INC.5$100
Novo Nordisk Inc5$96
Lundbeck LLC3$52
Exact Sciences Corporation2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Aimmune Therapeutics, Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Medtronic, Inc.1$17
Phathom Pharmaceuticals, Inc.2$17
Otsuka America Pharmaceutical, Inc.1$15

Products named: VRAYLAR, Ozempic, REXULTI, The Cologuard Plus Collection Kit, CAPLYTA, ZENPEP, XIFAXAN, INTELLIS ADAPTIVESTIM.

Industry payments across IN — which companies pay providers there.